Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Nu Skin Boasts Customer Growth, Faces Weak Gross Margin

Published 04/08/2019, 08:51 AM
Updated 07/09/2023, 06:31 AM
GIS
-
SYY
-
NUS
-
MED
-

Nu Skin Enterprises, Inc. (NYSE:NUS) is on rough seas, thanks to weak gross margins and adverse currency impacts. Nevertheless, this well-known cosmetics player is relying on growth programs, product launches and customer expansion to revive lost sheen. Let’s take a closer look.

Strong Customer Base Boosts Revenues

Nu Skin sells and distributes products through a network of sales leaders and customers, spread across 50 markets globally. Notably, the top line is consistently benefitting from growth in consumer count. In the fourth quarter of 2018, the company’s customers grew approximately 16%. This followed a respective rise of 9%, 8% and 7% in the third, the second and the first quarter of 2018. The company relies on social media as well as well-knit product and marketing programs to widen customer reach. We expect the company to keep gaining from an expanding customer base in the forthcoming periods as well.

Growth Programs On Track

With the help of advanced technology and well-strategized product programs, Nu Skin tries to capture greater market share and maintain growth momentum. In fact, the company’s long-term strategies are based on three factors — Products, Programs and Platforms. Notably, the launch of the revolutionary ageLOC LumiSpa has been a success. The company also introduced LumiSpa Accent in the fourth quarter and expects it to remain a growth driver in 2019. Apart from product launches, Nu Skin’s well-knit product strategies are driving growth in several market locations. It has also been working toward expanding sales compensation program — Velocity — across different nations.

Challenges in the Path

Nu Skin’s gross margin has been declining year over year for the past few quarters. Gross margin slid 140 basis points (bps) during fourth-quarter 2018. Also, gross margin declined approximately 190 bps, 180 bps and 140 bps during the third, the second and the first quarters of 2018, respectively. Such persistent declines pose considerable threats to the company’s overall profitability.

Additionally, adverse impacts from currency rates are weighing on the company’s performance. Markedly, the bottom line in the fourth quarter was hurt by foreign currency translation. Also, the top line in the said period was hurt by 4% negative impact from foreign currency changes. Going ahead, management expects foreign currency fluctuations to negatively impact the company’s top line in the first quarter and full year 2019 by 5-6% and 2-3%, respectively.

We note that such headwinds are marring investors’ optimism. Evidently, the company’s shares have plummeted roughly 17% in the past three months, against the industry’s rally of 26.1%.



Final Thoughts

We expect this Zacks Rank #3 (Hold) company to overcome the aforementioned hurdles, backed by underlying strength in sales leaders and customers. In fact, supported by such upsides and robust operational strategies, Nu Skin’s top line have been improving year on year in the past five quarters. In fact, management expects revenues to grow in 2019 as well. We expect such upsides to keep fueling the company and revive the stock’s lost sheen in the forthcoming periods.

Don’t Miss These Solid Food Stocks

MEDIFAST (NYSE:MED) , with long-term earnings growth rate of 20%, sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

General Mills (NYSE:GIS) , with a Zacks Rank #2 (Buy), has long-term earnings per share (EPS) growth rate of 7.5%.

Sysco Corporation (NYSE:SYY) , with long-term EPS growth rate of 10.3%, carries a Zacks Rank #2.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>



Nu Skin Enterprises, Inc. (NUS): Free Stock Analysis Report

Sysco Corporation (SYY): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.